cust.co / NRR Benchmark / Healthcare SaaS

Healthcare SaaS NRR Benchmark

Net Revenue Retention across 7 healthcare saas companies in the cust.co dataset, aggregated across all funding stages and ACV bands.

/
Latest median NRR · FY-2026
109%
down -7pp QoQ · up +0pp YoY
7 companies
65 verified disclosures
P25–P75: 97% – 119%

NRR over time - vertical-wide

80%100%120%140%160%180% 100% 2020-Q32022-Q12023-Q22025-Q2FY21FY26 Median NRR (vertical) Shaded area: 25th–75th percentile range across contributing companies 2020-Q3 - 167% (DOCS) 2020-Q4 - 173% (DOCS) 2021-Q2 - 139% (DOCS) 2021-Q3 - 139% (DOCS) 2021-Q4 - 128% (DOCS) 2022-Q1 - 133% (DOCS) 2022-Q4 - 104% (NRC) 2022-Q2 - 153% (DOCS) 2023-Q3 - 114% (OPRX, DOCS, NRC) 2023-Q4 - 101% (NRC, OPRX, GH, EVCM, DH) 2023-Q2 - 117% (DOCS) 2024-Q1 - 92% (DH, EVCM) 2024-Q2 - 114% (DOCS, OPRX, EVCM) 2024-Q3 - 110% (DOCS, EVCM, OPRX, NRC) 2024-Q4 - 102% (DOCS, EVCM, OPRX, NRC, DH, HCAT) 2025-Q2 - 118% (DOCS, OPRX, EVCM) 2025-Q3 - 101% (DOCS, EVCM, OPRX, HCAT, NRC) 2025-Q4 - 101% (DOCS, OPRX, EVCM, HCAT, NRC) 2026-Q1 - 109% (EVCM, OPRX, DOCS) 2026-Q2 - 94% (EVCM, DOCS, OPRX) FY-2021 - 117% (DOCS) FY-2022 - 112% (DOCS, NRC) FY-2023 - 109% (GH, NRC) FY-2024 - 121% (OPRX) 2025-Q1 - 109% (EVCM, OPRX, DOCS, HCAT) FY-2025 - 116% (DOCS, OPRX, HCAT) FY-2026 - 109% (DOCS) 173% peak 109% P25–P75 spread
2020-Q3 → FY-2026

Each point is the median across all healthcare saas companies that disclosed in that period. Shaded area = 25th-75th percentile range.

Cells in this vertical

2 (stage × ACV band) cells with verified data. Click a row to drill into peer-cell distribution + top performers.

StageACV bandLatest medianHistorySample
Public $25K-$100K ACV 107% FY2021-Q2: 167%FY2021-Q3: 173%FY-2021: 117%FY2022-Q1: 139%FY2022-Q2: 139%FY2022-Q3: 128%FY2022-Q4: 133%FY-2022: 119%FY2023-Q1: 153%FY2024-Q2: 114%FY-2023: 117%FY2023-Q4: 103%FY2024-Q1: 101%FY2025-Q1: 114%FY2025-Q2: 119%FY2025-Q3: 117%FY2024-Q4: 85%FY2025-Q4: 119%FY-2025: 119%FY2026-Q1: 118%FY2026-Q2: 118%FY2026-Q3: 112%FY2026-Q4: 109%FY-2026: 109%FY2027-Q1: 107% 3 co · 27 obs View →
Public $100K-$500K ACV 90% FY-2022: 105%FY2022-Q4: 104%FY2023-Q3: 115%FY-2023: 101%FY2023-Q4: 111%FY2024-Q2: 124%FY2024-Q3: 114%FY-2024: 121%FY2024-Q4: 112%FY2025-Q1: 114%FY2025-Q2: 121%FY2025-Q3: 111%FY-2025: 116%FY2025-Q4: 109%FY2026-Q1: 110%FY2026-Q2: 90% 2 co · 22 obs View →

Companies in this vertical

7 verified companies. Showing top 7 alphabetically.

Definitive Healthcare DH
85%
Public · $25K-$100K ACV
FY2023-Q4: 90%FY2024-Q1: 85%FY2024-Q4: 85%
Doximity DOCS
107%
Public · $25K-$100K ACV
FY2021-Q2: 167%FY2021-Q3: 173%FY-2021: 117%FY2022-Q1: 139%FY2022-Q2: 139%FY2022-Q3: 128%FY2022-Q4: 133%FY-2022: 119%FY2023-Q1: 153%FY2024-Q1: 117%FY2024-Q2: 114%FY2025-Q1: 114%FY2025-Q2: 119%FY2025-Q3: 117%FY2025-Q4: 119%FY-2025: 119%FY2026-Q1: 118%FY2026-Q2: 118%FY2026-Q3: 112%FY2026-Q4: 109%FY-2026: 109%FY2027-Q1: 107%
EverCommerce EVCM
94%
Public · $5K-$25K ACV
FY2023-Q4: 93%FY2024-Q1: 99%FY2024-Q2: 97%FY2024-Q3: 97%FY2024-Q4: 96%FY2025-Q1: 97%FY2025-Q2: 97%FY2025-Q3: 97%FY2025-Q4: 96%FY2026-Q1: 95%FY2026-Q2: 94%
Guardant Health GH
117%
Public · $25K-$100K ACV
FY-2023: 117%FY2023-Q4: 117%
Health Catalyst HCAT
92%
Public · $500K+ ACV
FY2024-Q4: 100%FY2025-Q1: 103%FY2025-Q3: 92%FY2025-Q4: 93%FY-2025: 92%
National Research NRC
101%
Public · $100K-$500K ACV
FY-2022: 105%FY2022-Q4: 104%FY2023-Q3: 102%FY-2023: 101%FY2023-Q4: 101%FY2024-Q3: 101%FY2024-Q4: 103%FY2025-Q3: 101%FY2025-Q4: 101%
OptimizeRx OPRX
90%
Public · $100K-$500K ACV
FY2023-Q3: 127%FY2023-Q4: 121%FY2024-Q2: 124%FY2024-Q3: 127%FY-2024: 121%FY2024-Q4: 121%FY2025-Q1: 114%FY2025-Q2: 121%FY2025-Q3: 120%FY-2025: 116%FY2025-Q4: 116%FY2026-Q1: 110%FY2026-Q2: 90%

How does your NRR compare to healthcare saas peers?

Results in 30 seconds. We email a shareable percentile badge.

Compute your NRR →